Despite the urgent need for effective treatments, the FDA has not approved any drugs that can prevent the decline of health in PD patients. This absence is attributed to the pharmaceutical industry's focus on patentable chemicals, prioritizing profits over patients.
A recent study recognizes the failure of pharmaceuticals in preventing Parkinson's disease progression and suggests exercise as a potential disease-modifying therapy. The importance of exercise in managing PD is supported by multiple studies highlighting its beneficial effects on patients' quality of life and potentially disease progression.
[
add
]
[
|
|
...
]